サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1308345

肺マーカー市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 141 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
肺マーカー市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年07月05日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

肺マーカーの世界市場規模は2022年に3億9,300万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に11.5%の成長率（CAGR）を示し、市場は2028年までに7億3,100万米ドルに達すると予測しています。

一般に、EGFR、EML4-ALK、KRAS、BRAFを含む4種類の主要な肺マーカーは、肺の介入処置や肺の手術、診断の際に使用されます。さらに、マーカーは腫瘍の検出、診断、予測、モニタリングに使用され、それに基づいて患者に治療が処方されます。肺マーカーは、いくつかの画像検査や生検とともに、がんを特定するための追加ツールとしてのみ使用されます。このため、肺マーカーは病院、外来外科クリニック、専門クリニックなどの医療施設での胸腔鏡手術に広く使用されています。

肺マーカーの需要の高まりは、大気汚染レベルの上昇により、胸水、胸膜中皮腫、胸膜プラークなどの呼吸器疾患の有病率が世界的に高いことに起因しています。これに加えて、受動喫煙への高い曝露と肺がんの家族歴が、肺がんに罹患する患者数をさらに増加させ、肺マーカーの需要を増大させる。さらに、老年人口の急増と、喫煙率の高さにつながる多忙な消費者のライフスタイルが、いくつかの呼吸器疾患のリスクをさらに加速させています。これとは別に、肺がんなどの生命を脅かす疾患の早期診断と前治療のために、さまざまな政府によるヘルスケア支出が増加していることも、世界レベルでの肺マーカーの利用率上昇を後押ししています。さらに、肺がんの診断と治療の分野におけるいくつかの研究開発活動への投資が増加していることも、肺マーカーの需要をさらに刺激しています。これに加えて、病院、手術センター、診療所での肺マーカーの使用量の増加や、治療目的でのさまざまな応用も、製品需要を刺激しています。

本レポートで扱う主な質問

  • 肺マーカーの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 肺マーカーの世界市場におけるCOVID-19の影響は？
  • 主要な地域市場は？
  • がんタイプ別の市場内訳は？
  • マーカータイプ別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 肺マーカーの世界市場構造と主要プレイヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 肺マーカーの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：がんタイプ別

  • 非小細胞肺がん（NSCLC）
    • 市場動向
    • 市場予測
  • 小細胞肺がん（SCLC）
    • 市場動向
    • 市場予測

第7章 市場内訳：マーカータイプ別

  • EGFR
    • 市場動向
    • 市場予測
  • EML4-ALK
    • 市場動向
    • 市場予測
  • KRAS
    • 市場動向
    • 市場予測
  • BRAF
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診断ラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • アルゼンチン
      • 市場動向
      • 市場予測
    • コロンビア
      • 市場動向
      • 市場予測
    • チリ
      • 市場動向
      • 市場予測
    • ペルー
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ
    • トルコ
      • 市場動向
      • 市場予測
    • イラン
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格指標

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc.
    • Fujirebio Europe N.V., Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • BioSpace, Inc.
図表

List of Figures

  • Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
  • Figure 2: Global: Lung Marker Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2022
  • Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2022
  • Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2022
  • Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Turkey: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Iran: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Argentina: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Colombia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Chile: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Peru: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Global: Lung Marker Industry: SWOT Analysis
  • Figure 91: Global: Lung Marker Industry: Value Chain Analysis
  • Figure 92: Global: Lung Marker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Lung Marker Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
  • Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million US$), 2023-2028
  • Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Lung Marker Market: Competitive Structure
  • Table 7: Global: Lung Marker Market: Key Players
目次
Product Code: SR112023A2063

Market Overview:

The global lung marker market size reached US$ 393.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 731.0 Million by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global lung marker market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cancer type, marker type and end user.

Breakup by Cancer Type:

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

EGFR

EML4-ALK

KRAS

BRAF

Others

Breakup by End User:

Hospitals

Diagnostic Labs

Others

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Peru

Others

Middle East and Africa

Turkey

Iran

Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Lung Marker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Non-Small Cell Lung Cancer (NSCLC)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Cell Lung Cancer (SCLC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Marker Type

  • 7.1 EGFR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 EML4-ALK
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 KRAS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 BRAF
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Iran
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Others
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Thermo Fisher Scientific Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agilent Technologies, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fujirebio Europe N.V., Hologic, Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Siemens Healthineers
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 BioSpace, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis